All sites C00-96,D32-33,D42-43,D45-47,D76 3303 90.3 2.3 2.7 0.9 3.8
Mouth, pharynx C00-14 50 94.0 2.0 0.4 0.8 2.8
  Lip C00 5 95.8 - - 4.2 -
  Tongue C02 11 98.2 - - 1.8 -
  Mouth, other C03-06 14 94.4 - 1.4 - 4.2
  Salivary glands C07-08 8 84.6 7.7 - - 7.7
  Pharynx C01,C09-14 12 94.8 3.4 - - 1.7
Digestive organs C15-26 590 82.9 1.9 7.3 1.9 6.1
  Oesophagus C15 19 90.6 1.0 4.2 3.1 1.0
  Stomach C16 60 93.4 0.7 2.0 0.7 3.3
  Small intestine C17 11 94.3 - 1.9 1.9 1.9
  Colon C18 195 96.1 - 1.4 0.4 2.0
  Rectum, rectosigmoid C19-20 97 95.5 - 0.8 1.4 2.3
  Anus C21 4 95.5 4.5 - - -
  Liver C22 38 72.6 1.1 15.3 3.2 7.9
  Gallbladder, bile ducts C23-24 40 63.1 5.6 14.1 1.5 15.7
  Pancreas C25 114 55.8 6.5 20.5 4.2 13.0
  Other digestive organs C26 12 40.7 1.7 20.3 8.5 28.8
Respiratory organs C30-39 162 75.6 11.1 6.8 0.9 5.6
  Nose, sinuses C30-31 4 100.0 - - - -
  Larynx, epiglottis C32 2 100.0 - - - -
  Lung, trachea C33-34 152 76.0 11.7 6.3 0.9 5.1
  Mediastinum, pleura C38 2 12.5 - 62.5 - 25.0
Bone C40-41 5 91.7 - 4.2 - 4.2
Melanoma of the skin C43 142 99.9 - - - 0.1
Skin, non-melanoma C44 199 99.7 0.1 0.1 - 0.1
Mesothelioma C45 3 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 26 95.4 1.5 - - 3.1
Breast C50 1042 99.2 0.2 0.1 0.2 0.3
Female genital organs C51-58 374 94.9 1.3 1.1 0.4 2.2
  Cervix uteri C53 34 98.8 - 0.6 0.6 -
  Corpus uteri C54 198 99.8 - 0.1 - 0.1
  Uterus, other C55,C58 1 14.3 - 14.3 14.3 57.1
  Ovary C56 97 85.5 4.3 3.3 0.8 6.0
  Other female genital C51-52,C57 44 93.2 1.8 0.9 0.9 3.2
Urinary organs C64-68 145 88.8 1.0 3.4 1.4 5.4
  Kidney C64 88 85.2 0.2 5.5 1.6 7.5
  Bladder and urinary tract2 C65-68 57 94.4 2.1 0.3 1.0 2.1
Eye C69 2 58.3 8.3 8.3 25.0 -
Brain, central nervous system C70-72,D32-33,D42-43 110 85.7 - 6.0 0.9 7.4
Thyroid gland C73 72 96.7 2.8 - - 0.6
Other endocrine glands C74-75 3 87.5 - - - 12.5
Illdefined or unknown C76,C80 86 54.3 12.1 14.8 4.9 13.9
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 292 75.3 8.8 1.2 2.1 12.5
  Hodgkin lymphoma C81 14 97.2 1.4 - - 1.4
  Non-Hodgkin lymphoma C82-86,C96,D76 127 97.9 0.5 0.2 0.2 1.3
  Malignant immunoproliferative diseases C88 4 72.2 5.6 - 5.6 16.7
  Myeloma and other plasma cell tumors C90 38 51.8 7.9 6.8 5.2 28.3
  Leukaemia C91-95 66 60.1 20.8 0.6 3.0 15.4
  Myelodysplastic syndromes D46 14 23.9 23.9 2.8 2.8 46.5
  Myeloproliferaitive neoplasms D45,D47 29 56.6 16.1 - 4.9 22.4
Not included above
  Carcinoma in situ of the breast D05 87 99.8 - - - 0.2
  Cervix uteri, non-invasive neoplasms 260 100.0 - - - -
  Borderline tumour of the ovary D39 37 97.8 - 1.1 - 1.1
  Basal cell carcinoma of the skin 892 100.0 - - 0.0 -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.